secwatch.observer — SEC 8-K summary
======================================

Issuer:     FULLER H B CO (FUL)
CIK:        0000039368
Form:       8-K
Filed at:   2025-10-08T23:59:59+00:00
Accession:  0001437749-25-030677
Event type: leadership
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

H.B. Fuller appoints former J&J MedTech executive Celine Martin to board
------------------------------------------------------------------------

- Celine Martin, 51, elected as Class III director effective Dec. 1, 2025, serving on Audit and Compensation Committees.
- Martin most recently served as Company Group Chairman, Cardiovascular & Specialty Solutions at Johnson & Johnson MedTech (2022–2025).
- Appointment supports H.B. Fuller's strategic expansion into high-margin medical adhesives and goal of >20% EBITDA margin.
- Board size increases to nine directors, eight independent; Martin receives $100K cash retainer and 1,300 RSUs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/39368/000143774925030677/0001437749-25-030677-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/39368/000143774925030677/ful20251007_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-030677

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer